
Yabao Pharmaceutical Group Co., Ltd
SSE:600351.SS
6.25 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,686.038 | 2,909.765 | 2,718.135 | 2,763.962 | 2,602.423 | 3,041.916 | 2,918.099 | 2,558.515 | 1,806.11 | 2,065.627 | 1,889.657 | 1,624.883 | 1,266.573 | 1,662.746 | 1,181.822 | 1,488.266 | 1,254.652 | 986.055 | 741.3 | 685.783 | 596.803 | 373.49 | 212.628 | 154.552 | 133.597 | 125.564 |
Cost of Revenue
| 1,297.853 | 1,245.558 | 1,199.376 | 1,077.119 | 1,058.707 | 1,108.1 | 1,164.611 | 1,115.864 | 1,009.67 | 979.649 | 896.746 | 885.635 | 617.273 | 909.638 | 634.962 | 969.279 | 839.951 | 645.39 | 477.926 | 443.786 | 385.267 | 203.022 | 96.6 | 74.887 | 62.668 | 70.361 |
Gross Profit
| 1,388.184 | 1,664.207 | 1,518.759 | 1,686.843 | 1,543.716 | 1,933.816 | 1,753.488 | 1,442.651 | 796.441 | 1,085.978 | 992.912 | 739.248 | 649.3 | 753.108 | 546.86 | 518.988 | 414.701 | 340.665 | 263.374 | 241.997 | 211.537 | 170.468 | 116.028 | 79.665 | 70.929 | 55.203 |
Gross Profit Ratio
| 0.517 | 0.572 | 0.559 | 0.61 | 0.593 | 0.636 | 0.601 | 0.564 | 0.441 | 0.526 | 0.525 | 0.455 | 0.513 | 0.453 | 0.463 | 0.349 | 0.331 | 0.345 | 0.355 | 0.353 | 0.354 | 0.456 | 0.546 | 0.515 | 0.531 | 0.44 |
Reseach & Development Expenses
| 139.523 | 118.29 | 130.616 | 157.125 | 144.463 | 112.79 | 112.128 | 140.698 | 84.49 | 54.517 | 56.092 | 23.482 | 32.848 | 18.554 | 8.697 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 99.441 | 57.47 | 53.401 | 57.158 | 57.771 | 67.675 | 66.833 | 64.019 | 79.922 | 64.902 | 61.769 | 62.857 | 56.169 | 53.91 | 51.256 | 124.401 | 113.244 | 76.303 | 76.728 | 73.411 | 56.543 | 48.197 | 31.475 | 19.127 | 20.445 | 21.673 |
Selling & Marketing Expenses
| 509.413 | 971.691 | 897.466 | 1,043.311 | 980.718 | 1,138.557 | 962.264 | 694.22 | 438.432 | 452.488 | 426.358 | 341.279 | 282.45 | 214.505 | 205.586 | 207.564 | 160.565 | 169.574 | 133.042 | 107.526 | 88.508 | 71.648 | 41.12 | 24.967 | 22.12 | 16.736 |
SG&A
| 608.854 | 1,029.16 | 950.867 | 1,100.469 | 1,038.489 | 1,206.233 | 1,029.098 | 758.239 | 518.354 | 517.39 | 488.127 | 404.137 | 338.619 | 268.415 | 256.841 | 331.965 | 273.809 | 245.877 | 209.77 | 180.937 | 145.051 | 119.845 | 72.595 | 44.094 | 42.565 | 38.409 |
Other Expenses
| 339.854 | 290.422 | 222.744 | 205.18 | 198.838 | 220.425 | -0.899 | -3.747 | 89.575 | 24.886 | 11.245 | 45.995 | 38.678 | 25.109 | 5.945 | 3.465 | 5.458 | 0.619 | -0.536 | 1.494 | -0.205 | 0.609 | -0.421 | 6.358 | 4.332 | -0.045 |
Operating Expenses
| 1,088.231 | 1,437.872 | 1,304.227 | 1,462.774 | 1,381.791 | 1,539.447 | 1,376.164 | 1,158.622 | 826.742 | 822.027 | 763.109 | 603.229 | 505.649 | 460.923 | 363.596 | 340.997 | 281.78 | 253.128 | 215.01 | 185.603 | 148.904 | 122.875 | 74.944 | 45.45 | 43.839 | 39.607 |
Operating Income
| 299.953 | 226.335 | 220.399 | 203.217 | 127.347 | 378.525 | 330.864 | 228.429 | -60.416 | 224.155 | 183.613 | 90.632 | 91.138 | 229.087 | 159.634 | 152.992 | 106.056 | 66.847 | 25.098 | 30.104 | 44.785 | 38.742 | 31.343 | 27.95 | 23.305 | 9.89 |
Operating Income Ratio
| 0.112 | 0.078 | 0.081 | 0.074 | 0.049 | 0.124 | 0.113 | 0.089 | -0.033 | 0.109 | 0.097 | 0.056 | 0.072 | 0.138 | 0.135 | 0.103 | 0.085 | 0.068 | 0.034 | 0.044 | 0.075 | 0.104 | 0.147 | 0.181 | 0.174 | 0.079 |
Total Other Income Expenses Net
| -7.845 | -7.354 | 2.1 | -1.625 | 0.071 | 3.872 | -0.899 | -3.747 | 31.036 | 23.67 | 6.449 | 39.51 | 37.886 | -46.139 | -18.611 | -21.862 | -21.497 | -20.071 | -26.929 | -27.393 | -19.522 | -0.499 | -0.869 | -0.494 | 0.34 | -0.012 |
Income Before Tax
| 292.108 | 218.981 | 125.647 | 201.593 | 127.418 | 49.875 | 329.965 | 224.682 | 27.818 | 247.825 | 190.062 | 130.142 | 129.023 | 241.403 | 162.744 | 155.683 | 111.423 | 67.466 | 23.563 | 30.299 | 43.845 | 38.331 | 30.473 | 27.456 | 23.645 | 9.878 |
Income Before Tax Ratio
| 0.109 | 0.075 | 0.046 | 0.073 | 0.049 | 0.016 | 0.113 | 0.088 | 0.015 | 0.12 | 0.101 | 0.08 | 0.102 | 0.145 | 0.138 | 0.105 | 0.089 | 0.068 | 0.032 | 0.044 | 0.073 | 0.103 | 0.143 | 0.178 | 0.177 | 0.079 |
Income Tax Expense
| 68.193 | 39.068 | 21.043 | 17.83 | 18.431 | 39.077 | 45.946 | 24.861 | 0.778 | 29.777 | 24.955 | 16.882 | 19.156 | 43.994 | 23.348 | 27.522 | 24.66 | 19.514 | 9.383 | 13.423 | 15.721 | 13.654 | 10.535 | 9.198 | 8.335 | 3.347 |
Net Income
| 242.688 | 199.586 | 104.655 | 187.089 | 107.369 | 10.799 | 273.335 | 200.206 | 22.522 | 222.09 | 170.122 | 118.196 | 112.287 | 186.431 | 144.302 | 129.294 | 85.456 | 45.06 | 21.822 | 24.361 | 31.251 | 24.974 | 19.459 | 17.966 | 14.526 | 6.794 |
Net Income Ratio
| 0.09 | 0.069 | 0.039 | 0.068 | 0.041 | 0.004 | 0.094 | 0.078 | 0.012 | 0.108 | 0.09 | 0.073 | 0.089 | 0.112 | 0.122 | 0.087 | 0.068 | 0.046 | 0.029 | 0.036 | 0.052 | 0.067 | 0.092 | 0.116 | 0.109 | 0.054 |
EPS
| 0.34 | 0.26 | 0.14 | 0.24 | 0.14 | 0.014 | 0.35 | 0.25 | 0.029 | 0.32 | 0.25 | 0.17 | 0.17 | 0.29 | 0.23 | 0.2 | 0.29 | 0.098 | 0.043 | 0.035 | 0.045 | 0.036 | 0.028 | 0.033 | 0.026 | 0.012 |
EPS Diluted
| 0.34 | 0.26 | 0.14 | 0.24 | 0.14 | 0.014 | 0.35 | 0.25 | 0.029 | 0.32 | 0.25 | 0.17 | 0.17 | 0.29 | 0.23 | 0.2 | 0.29 | 0.098 | 0.043 | 0.035 | 0.045 | 0.036 | 0.028 | 0.033 | 0.026 | 0.012 |
EBITDA
| 437.956 | 391.764 | 309.68 | 398.743 | 338.399 | 284.16 | 515.577 | 441.913 | 220.726 | 397.17 | 366.119 | 271.898 | 271.416 | 360.929 | 246.55 | 230.467 | 181.724 | 130.64 | 82.762 | 87.238 | 80.722 | 62.045 | 47.379 | 39.356 | 27.74 | 15.596 |
EBITDA Ratio
| 0.163 | 0.135 | 0.114 | 0.144 | 0.13 | 0.093 | 0.177 | 0.173 | 0.122 | 0.192 | 0.194 | 0.167 | 0.214 | 0.217 | 0.209 | 0.155 | 0.145 | 0.132 | 0.112 | 0.127 | 0.135 | 0.166 | 0.223 | 0.255 | 0.208 | 0.124 |